Form 4 for SLDB Solid Biosciences Inc.
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-02 · accession 0000899243-22-037693 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-05 | 2022-12-02 | SLDB | SMITH IAN F | Dir | A - Grant | — | +13.2K | 356.4K | +4% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-02 | A | A | 13,172 | — | 356,380 | D | — | — | (F1) The reporting person acquired 13,172 shares of the issuer's common stock pursuant to the issuer's acquisition of all of the outstanding capital stock of AavantiBio, Inc. on December 2, 2022. |